This presentation, entitled "Technology Transfer 101: Taking Discoveries from Lab Bench to the Marketplace," was originally given by Michael Waring (Executive Director of Federal Relations, University of Michigan) to the AUTM Board in October 2012.

 Remarks by University of Maryland Chancellor William E. Kirwan at a December 1, 2010, celebration of the 30th anniversary of the Bayh-Dole Act. 

 http://jec.senate.gov/public//index.cfm?a=Files.Serve&File_id=12c7d3d8-42c9-4112-a7fe-bfac5be72082 

Presentation by Andy Cohn, WARF Overview, Wisconsin Alumni Research Foundation, May 4, 2010

Presentation by John S. Swartley, MBA, Ph.D., Deputy Executive Director, Center for Technology Transfer, University of Pennsylvania, at AAU CFR Meeting titled “TECH TRANSFER 101: Technology Commercialization and New Business Creation within Universities," May 4, 2010

Presentation on Bayh-Dole and Technology Transfer: The NIH Experience by Mark Rohrbaugh, Ph.D., J.D., Director of the Office of Technology Transfer, National Institutes of Health

Licensing approaches, even for comparable technologies, can vary considerably from case to case and from institution to institution based on circumstances particular to each specific invention, business opportunity, licensee and university. In spite of this uniqueness, universities share certain core values that can and should be maintained to the fullest extent possible in all technology transfer agreements. In the summer of 2006, Stanford University’s then Dean of Research Arthur Bienenstock convened a small meeting of research officers, licensing directors and a representative from the Association of American Medical Colleges to brainstorm about important societal, policy, legislative and other issues in university technology transfer..

The nation's top research universities and the Association of American Medical Colleges (AAMC) today issued a set of shared guidelines intended to protect the public interest when universities grant licenses for the rights to their latest scientific advances to private parties. The white paper—titled "In the Public Interest: Nine Points to Consider in Licensing University Technology"—aims to encourage technology transfer agreements to facilitate broad development and dissemination of university-generated technologies..

This review looks at technology licensing practices that have a very long and established history in the United States. Technology transfer practices are embedded in the earliest national defense research, activities of the Extension Services, especially the Agricultural Extension Services, and the preparation of scientific publications that date back nearly 100 years. The nation evolved rapidly during and after World War II from one with very little technical development work or interest in intellectual property, to one leading a revolution in several technological disciplines. The increasingly sophisticated military demands of this era caused a dramatic increase in technological research, as it quickly became apparent that the government alone was not able to conduct the range and number of scientific projects needed to win a war. These priorities gave rise to a rapid evolution of government funded research and development contracts, which further proliferated with the commencement of substantial federal funding for disease related medical research in 1950..

We commend the NIH for its thoughtful and comprehensive response to Congress' request for analysis of the public interest in securing an appropriate return on the nation's investment in basic research. This is an excellent report and one that illuminates the essential role of publicly funded research in drug development. Key among the NIH's conclusions is the finding that, two decades out from the inception of Bayh-Dole, the nation's system of biomedical discovery and technology transfer is working well..